Hypoxia Mimetic Agents for Ischemic Stroke
Every year stroke claims more than 6 million lives worldwide. The majority of them are ischemic stroke. Small molecule-based therapeutics for ischemic stroke has attracted a lot of attention, but none has been shown to be clinically useful so far. Hypoxia-inducible factor-1 (HIF-1) plays a crucial r...
Main Authors: | Charles K. Davis, Saurabh A. Jain, Ok-Nam Bae, Arshad Majid, G. K. Rajanikant |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2018.00175/full |
Similar Items
-
Hypoxia related long non-coding RNAs in ischemic stroke
by: Jiawei Yao, et al.
Published: (2021-12-01) -
Editorial: The Development of New Classes of Hypoxia Mimetic Agents for Clinical Use
by: Ruoli Chen, et al.
Published: (2019-06-01) -
Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats
by: Xiang Yao, et al.
Published: (2021-05-01) -
Exploring How Low Oxygen Post Conditioning Improves Stroke-Induced Cognitive Impairment: A Consideration of Amyloid-Beta Loading and Other Mechanisms
by: Zidan Zhao, et al.
Published: (2021-03-01) -
Study of Iron Piperazine-Based Chelators as Potential Siderophore Mimetics
by: Pauline Loupias, et al.
Published: (2019-10-01)